Alex Brill Writes to FTC Regarding Interim Pharmacy Benefit Manager Report
In July, MGA CEO Alex Brill submitted a comment letter to the Federal Trade Commission (FTC) expressing concerns about their newly released interim report, “Pharmacy Benefit Managers: The Powerful Middlemen Inflating Drug Costs and Squeezing Main Street Pharmacies.” As Brill noted, the interim report “is lacking in substantive evidence and appears both unbalanced and biased… The lack of rigorous economic inquiry in the interim report and the failure to present evidence related to PBMs’ effect on consumers suggest that further FTC action will reflect an insufficient understanding of the complexity of this market and the benefits of PBMs generally.”
Read the letter here.
